Dihydrotestosterone treatment rescues the decline in protein synthesis as a result of sarcopenia in isolated mouse skeletal muscle fibres
Open Access
- 25 April 2016
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 8 (1) , 48-56
Abstract
Background: Sarcopenia, the progressive decline in skeletal muscle mass and function with age, is a debilitating condition. It leads to inactivity, falls, and loss of independence. Despite this, its cause(s) and the underlying mechanism(s) are still poorly understood.Methods: In this study, small skeletal muscle fibre bundles isolated from the extensor digitorum longus (a fast‐twitch muscle) and the soleus (a slow‐twitch muscle) of adult mice of different ages (range 100–900 days old) were used to investigate the effects of ageing and dihydrotestosterone (DHT) treatment on protein synthesis as well as the expression and function of two amino acid transporters; the sodium‐coupled neutral amino acid transporter (SNAT) 2, and the sodium‐independent L‐type amino‐acid transporter (LAT) 2.Results: At all ages investigated, protein synthesis was always higher in the slow‐twitch than in the fast‐twitch muscle fibres and decreased with age in both fibre types. However, the decline was greater in the fast‐twitch than in the slow‐twitch fibres and was accompanied by a reduction in the expression of SNAT2 and LAT2 at the protein level. Again, the decrease in the expression of the amino acid transporters was greater in the fast‐twitch than in the slow‐twitch fibres. In contrast, ageing had no effect on SNAT2 and LAT2 expressions at the mRNA level. Treating the muscle fibre bundles with physiological concentrations (~2 nM) of DHT for 1 h completely reversed the effects of ageing on protein synthesis and the expression of SNAT2 and LAT2 protein in both fibre types.Conclusion: From the observations that ageing is accompanied by a reduction in protein synthesis and transporter expression and that these effects are reversed by DHT treatment, we conclude that sarcopenia arises from an age‐dependent reduction in protein synthesis caused, in part, by the lack of or by the low bioavailability of the male sex steroid, DHT.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/J01754X/1)
This publication has 36 references indexed in Scilit:
- Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2‐dependent mechanismThe Journal of Physiology, 2011
- A new method to study in vivo protein synthesis in slow- and fast-twitch muscle fibers and initial measurements in humansJournal of Applied Physiology, 2010
- Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibresThe Journal of Physiology, 2010
- Amino acid transceptors: gate keepers of nutrient exchange and regulators of nutrient signalingAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Management of the Cardinal Features of AndropauseAmerican Journal of Therapeutics, 2006
- Age-related differences in skeletal muscle protein synthesis: relation to markers of immune activationAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Risks of Testosterone-Replacement Therapy and Recommendations for MonitoringNew England Journal of Medicine, 2004
- Sarcopenia—consequences, mechanisms, and potential therapiesMechanisms of Ageing and Development, 2003
- Insulin Promotes the Cell Surface Recruitment of the SAT2/ATA2 System A Amino Acid Transporter from an Endosomal Compartment in Skeletal Muscle CellsJournal of Biological Chemistry, 2002
- Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal MenThe Journal of Clinical Endocrinology & Metabolism, 1997